Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ATEX
ATEX logo

ATEX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Anterix Inc (ATEX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
39.110
1 Day change
2.41%
52 Week Range
41.000
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Anterix Inc (ATEX) is not a strong buy at the moment given the user's long-term investment strategy and beginner-level knowledge. The stock shows weak financial performance, no significant trading trends, and lacks positive catalysts or strong technical signals. Holding off for now is recommended.

Technical Analysis

The stock's MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 50.586, and while moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the price has dropped significantly (-4.41% in regular trading). Support is at 36.858, and resistance is at 40.395. Overall, the technical indicators do not strongly suggest a buying opportunity.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a lack of bearish sentiment, but the extremely low option volume (5 contracts traded) suggests limited interest in the stock.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
8

Positive Catalysts

  • NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data.

Neutral/Negative Catalysts

  • Weak financial performance in Q3 2026, with net income and EPS dropping significantly (-185.62% and -185.37% YoY, respectively). The stock also experienced a sharp price decline (-4.41%) in the last trading session.

Financial Performance

In Q3 2026, revenue increased marginally by 0.45% YoY to $1,573,000. However, net income dropped significantly to -$6,601,000 (-185.62% YoY), and EPS fell to -0.35 (-185.37% YoY). Gross margin remained at 100%, but the overall financials indicate poor profitability and growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes are available for ATEX.

Wall Street analysts forecast ATEX stock price to rise
2 Analyst Rating
Wall Street analysts forecast ATEX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 39.110
sliders
Low
44
Averages
44
High
44
Current: 39.110
sliders
Low
44
Averages
44
High
44
JPMorgan
Sebastiano Petti
Overweight
downgrade
$67 -> $50
AI Analysis
2025-10-17
Reason
JPMorgan
Sebastiano Petti
Price Target
$67 -> $50
AI Analysis
2025-10-17
downgrade
Overweight
Reason
JPMorgan analyst Sebastiano Petti lowered the firm's price target on Anterix to $50 from $67 and keeps an Overweight rating on the shares. The company's accelerator program remains oversubscribed, but investors are still awaiting new deal signings, the analyst tells investors in a research note. The firm says Anterix attributes the delay to the overall complexity of the deals and the risk management processes of the utilities involved. JPMorgan finds the stock "very attractive" at current levels.

People Also Watch